<?xml version="1.0" encoding="UTF-8"?>
<ref id="CR45">
 <label>45.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Modjarrad</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Roberts</surname>
    <given-names>CC</given-names>
   </name>
   <name>
    <surname>Mills</surname>
    <given-names>KT</given-names>
   </name>
   <name>
    <surname>Castellano</surname>
    <given-names>AR</given-names>
   </name>
   <name>
    <surname>Paolino</surname>
    <given-names>K</given-names>
   </name>
   <name>
    <surname>Muthumani</surname>
    <given-names>K</given-names>
   </name>
   <etal/>
  </person-group>
  <article-title>Safety and immunogenicity of an anti-Middle East respiratory syndrome coronavirus DNA vaccine: a phase 1, open-label, single-arm, dose-escalation trial</article-title>
  <source>Lancet Infect Dis</source>
  <year>2019</year>
  <volume>19</volume>
  <issue>9</issue>
  <fpage>1013</fpage>
  <lpage>1022</lpage>
  <pub-id pub-id-type="doi">10.1016/S1473-3099(19)30266-X</pub-id>
  <?supplied-pmid 31351922?>
  <pub-id pub-id-type="pmid">31351922</pub-id>
 </element-citation>
</ref>
